In vitro activities of telithromycin against Staphylococcus aureus biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin

被引:15
|
作者
Zheng, Jin-xin [1 ,2 ,3 ,4 ,5 ,6 ]
Tu, Hao-peng [4 ,5 ,6 ]
Sun, Xiang [4 ,5 ,6 ]
Xu, Guang-jian [4 ,5 ,6 ]
Chen, Jun-wen [4 ,5 ,6 ]
Deng, Qi-wen [4 ,5 ,6 ]
Yu, Zhi-jian [4 ,5 ,6 ]
Qu, Di [1 ,2 ,3 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Educ,Key Lab Med Mol Virol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Hlth,Key Lab Med Mol Virol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China
[4] Shenzhen Univ, Hlth Sci Ctr, Shenzhen Nanshan Peoples Hosp, Dept Infect Dis, Shenzhen 518052, Peoples R China
[5] Shenzhen Univ, Hlth Sci Ctr, Shenzhen Nanshan Peoples Hosp, Key Lab Endogenous Infect, Shenzhen 518052, Peoples R China
[6] Shenzhen Univ, Hlth Sci Ctr, Affiliated Hosp 6, Shenzhen 518052, Peoples R China
关键词
Staphylococcus aureus; telithromycin; biofilm; adherent cells; subinhibitory concentrations; HIGH-DOSE DAPTOMYCIN; MODEL;
D O I
10.1099/jmm.0.001122
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction. Staphylococcus aureus biofilms are difficult to treat and the effect of telithromycin treatment is still unclear. Aim. This study aimed to explore the effect of telithromycin against Staphylococcus aureus biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin. Methodology. Eight methicillin-susceptible and eight methicillin-resistant S. aureus isolates (MSSA and MRSA, respectively) were used for this study. Biofilm biomasses were detected by crystal violet staining and the adherent cells in the established biofilms were quantified by determination of colony-forming units (c.f.u.). The RNA levels of biofilm formation-related genes were determined by RT-qPCR. Results. Telithromycin [8x minimum inhibitory concentration (MIC)] eradicated more established biofilms than azithromycin or clindamycin in the four MSSA isolates, and eliminated the established biofilms of six MRSA isolates more effectively than vancomycin or daptomycin. Telithromycin (8x MIC) killed more adherent cells in the established biofilms than azithromycin or clindamycin in the six MSSA isolates, and killed more adherent cells than vancomycin in all eight MRSA isolates. Daptomycin also showed an excellent effect on the adherent cells of MRSA isolates, with similarresults to telithromycin. The effect of a subinhibitory concentration of telithromycin (1/4x MIC) was significantly superior to that of azithromycin or clindamycin, inhibiting the biofilm formation of six MSSA isolates and seven MRSA isolates more effectively than vancomycin or daptomycin. The RNA levels of agrA, agrC, clfA, icaA and sigB decreased when treated with telithromycin (1/4x MIC). Conclusions. Telithromycin is more effective than azithromycin, clindamycin, vancomycin, or daptomycin against S. aureus biofilms.
引用
收藏
页码:120 / 131
页数:12
相关论文
共 50 条
  • [31] Pharmacodynamics of Moxifloxacin versus Vancomycin against Biofilms of Methicillin-Resistant Staphylococcus aureus and epidermidis in an In Vitro Model
    Salem, A. H.
    Elkhatib, W. F.
    Ahmed, G. F.
    Noreddin, A. M.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (04) : 238 - 242
  • [32] In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis
    Löwdin, E
    Odenholt, I
    Cars, O
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2739 - 2744
  • [33] In Vitro Activities of Daptomycin-, Vancomycin-, and Teicoplanin-Loaded Polymethylmethacrylate against Methicillin-Susceptible, Methicillin-Resistant, and Vancomycin-Intermediate Strains of Staphylococcus aureus
    Chang, Yuhan
    Chen, Wen-Chien
    Hsieh, Pang-Hsin
    Chen, Dave W.
    Lee, Mel S.
    Shih, Hsin-Nung
    Ueng, Steve W. N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) : 5480 - 5484
  • [34] In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
    Jevitt, LA
    Smith, AJ
    Williams, PP
    Raney, PM
    McGowan, JE
    Tenover, FC
    MICROBIAL DRUG RESISTANCE, 2003, 9 (04) : 389 - 393
  • [35] Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo
    Weiss, Elizabeth C.
    Zielinska, Agnieszka
    Beenken, Karen E.
    Spencer, Horace J.
    Daily, Sonja J.
    Smeltzer, Mark S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4096 - 4102
  • [36] In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis
    Laganas, V
    Alder, J
    Silverman, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) : 2682 - 2684
  • [37] In Vitro Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates to Vancomycin, Teicoplanin, Linezolide and Daptomycin
    Celikbilek, Nevreste
    Ozdem, Birsen
    Gurelik, Feryal C.
    Guvenman, Selda
    Guner, H. Rahmet
    Acikgoz, Ziya Cibali
    MIKROBIYOLOJI BULTENI, 2011, 45 (03): : 512 - 518
  • [38] Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
    Sakoulas, G
    Alder, J
    Thauvin-Eliopouios, C
    Moellering, RC
    Eliopoulos, GM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) : 1581 - 1585
  • [39] ANTI-ADHESIVE AND ANTI-BIOFILM ACTIVITIES IN VITRO OF LINEZOLID, VANCOMYCIN, TIGECYCLINE AND DAPTOMYCIN AGAINST STAPHYLOCOCCUS HAEMOLYTICUS
    Juda, Marek
    Helon, Pawel
    Malm, Anna
    ACTA POLONIAE PHARMACEUTICA, 2016, 73 (06): : 1539 - 1543
  • [40] The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin
    Sader, Helio S.
    Jones, Ronald N.
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (06) : 798 - 799